Susquehanna International Group, LLP Celldex Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 64,576 shares of CLDX stock, worth $1.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,576

Previous 47,817 35.05%

Holding current value

$1.52 Million

Previous $1.77 Million 23.97%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $537,293 - $746,781	16,759 Added 35.05%	64,576 $2.19 Million
Q2 2024 Aug 15, 2024	SELL	$32.76 - $42.56 $766,616 - $995,946	-23,401 Reduced 32.86%	47,817 $1.77 Million
Q1 2024 May 07, 2024	BUY	$35.22 - $51.88 $786,462 - $1.16 Million	22,330 Added 45.68%	71,218 $2.99 Million
Q4 2023 Feb 14, 2024	SELL	$22.61 - $40.65 $193,812 - $348,451	-8,572 Reduced 14.92%	48,888 $1.94 Million
Q3 2023 Nov 14, 2023	BUY	$25.45 - $37.46 $1.13 Million - $1.67 Million	44,576 Added 345.98%	57,460 $1.58 Million
Q2 2023 Aug 11, 2023	SELL	$30.29 - $38.28 $1.47 Million - $1.86 Million	-48,522 Reduced 79.02%	12,884 $437,000
Q1 2023 May 16, 2023	BUY	$34.78 - $47.43 $286,795 - $391,107	8,246 Added 15.51%	61,406 $2.21 Million
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $2.46 Million - $4.01 Million	-88,391 Reduced 62.44%	53,160 $2.37 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $2.71 Million - $4.49 Million	119,586 Added 544.44%	141,551 $3.98 Million
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $1.66 Million - $3.01 Million	-80,737 Reduced 78.61%	21,965 $592,000
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $503,407 - $716,135	18,213 Added 21.56%	102,702 $3.5 Million
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $2.48 Million - $3.91 Million	-69,471 Reduced 45.12%	84,489 $3.27 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $1.38 Million - $2.66 Million	47,512 Added 44.63%	153,960 $8.31 Million
Q2 2021 Aug 11, 2021	SELL	$20.71 - $35.37 $10.9 Million - $18.6 Million	-524,561 Reduced 83.13%	106,448 $3.56 Million
Q1 2021 May 17, 2021	BUY	$16.19 - $29.91 $5.17 Million - $9.55 Million	319,272 Added 102.42%	631,009 $13 Million
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $4.47 Million - $6.78 Million	297,874 Added 2148.7%	311,737 $5.46 Million
Q2 2020 Aug 14, 2020	SELL	$1.61 - $13.41 $31,069 - $258,786	-19,298 Reduced 58.19%	13,863 $180,000
Q1 2020 May 15, 2020	SELL	$1.55 - $3.07 $44,249 - $87,642	-28,548 Reduced 46.26%	33,161 $55,000
Q4 2019 Feb 14, 2020	BUY	$2.11 - $2.8 $44,850 - $59,516	21,256 Added 52.54%	61,709 $138,000
Q3 2019 Nov 14, 2019	BUY	$2.05 - $2.75 $33,970 - $45,570	16,571 Added 69.39%	40,453 $86,000
Q1 2019 May 15, 2019	BUY	$3.45 - $10.35 $82,392 - $247,178	23,882 New	23,882 $117,000

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.1B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Celldex Therapeutics, Inc. Transaction History